Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 12Leukemia 5Spondylitis, Ankylosing 3Psoriasis 3Myelodysplastic Syndromes 3Myeloproliferative Disorders 2Myelodysplastic-Myeloproliferative Diseases 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Arthritis, Psoriatic 2Spondylarthritis 1Respiratory Distress Syndrome 1Recurrence 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Neuroblastoma 1Neoplasms 1Neoplasm Metastasis 1Melanoma 1Lymphoma 1Lung Neoplasms 1Lung Injury 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Lymphocytic, Chronic, B-Cell 1Inflammatory Bowel Diseases 1Infections 1Immunoglobulin Light-chain Amyloidosis 1Hematologic Neoplasms 1HIV Infections 1Gulf War Illness 1

Interventions

Waist-Hip Ratio 1Waist Circumference 1Time 1Sex Characteristics 1Islets of Langerhans Transplantation 1Insulin 1High-Intensity Interval Training 1Exenatide 1Etanercept 1Continuous Glucose Monitoring 1Cardiovascular Physiological Phenomena 1Body Mass Index 1Body Composition 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Diabetes Mellitus, Type 1 × Etanercept × Clear all
NCT00566813 2021-04-06

Islet Transplantation in Type 1 Diabetic Patients Using the Edmonton Protocol of Steroid Free Immunosuppression

University of Illinois at Chicago

Phase 1/2 Completed
10 enrolled 10 charts

Diabetes Mellitus, Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡